+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Bone Cement Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 180 Pages
  • August 2024
  • Region: Asia Pacific
  • Expert Market Research
  • ID: 5926296
The Asia Pacific bone cement market was valued at USD 298.48 million in 2023, driven by the increasing number of orthopedic surgeries and rising innovations in bone cement formulations in the region. The market is expected to grow at a CAGR of 6.1% during the forecast period of 2024-2032, with the value likely to reach USD 508.57 million by 2032.

Asia Pacific Bone Cement Market Analysis

The Asia Pacific bone cement market plays a crucial role in orthopaedic surgeries, providing stability and support to implants such as hip and knee replacements. It is primarily composed of polymethyl methacrylate (PMMA) and offers benefits like rapid curing and high strength, making it ideal for fixing prosthetic joints.

Market Drivers

  • Rising Geriatric Population: The ageing demographic in Asia Pacific is driving the demand for orthopaedic procedures, thereby boosting the bone cement market.
  • Increasing Prevalence of Osteoporosis: Osteoporosis-related fractures are becoming more prevalent, necessitating surgeries where bone cement is used to stabilize fractures.
  • Technological Advancements: Innovations in bone cement formulations and delivery systems are enhancing surgical outcomes and patient recovery times.
  • Growing Healthcare Expenditure: Increasing healthcare spending in developing countries is expanding access to orthopaedic surgeries, thereby fuelling market growth.

Challenges

  • Regulatory Hurdles: Stringent regulatory requirements for medical devices can delay product approvals and market entry.
  • High Cost of Advanced Products: The initial cost of advanced bone cement technologies may limit adoption in less affluent regions.
  • Risk of Complications: Issues such as implant loosening and infection associated with bone cement pose challenges to market expansion.

Future Opportunities

  • Expanding Medical Tourism: Asia Pacific countries are emerging as hubs for medical tourism, offering opportunities for growth in orthopaedic procedures and bone cement demand.
  • Focus on Minimally Invasive Surgeries: Increasing preference for minimally invasive techniques presents opportunities for bone cement developers to innovate and improve product efficacy.
  • Emerging Markets: Untapped markets in rural areas present opportunities for market expansion with targeted healthcare initiatives and infrastructure development.

Asia Pacific Bone Cement Market Trends

The Asia Pacific bone cement market is experiencing notable growth, driven by an increasing number of orthopaedic surgeries and advancements in medical technology. This market is poised to expand further as healthcare infrastructure improves across the region.

Market Trends

  • Shift Towards Antibiotic-Loaded Bone Cement: There is a growing trend towards the use of antibiotic-loaded bone cement to reduce post-surgical infections. This type of cement helps in the localised delivery of antibiotics, minimising the risk of complications and improving patient outcomes.
  • Adoption of Biodegradable Bone Cements: The market is witnessing an increase in the development and use of biodegradable bone cements. These cements offer the advantage of being resorbed by the body over time, eliminating the need for removal surgeries and reducing long-term complications.
  • Customised Solutions Through 3D Printing: 3D printing technology is being increasingly utilised to create customised bone cement solutions tailored to individual patient anatomies. This trend enhances the precision and effectiveness of orthopaedic implants, leading to better surgical outcomes.
  • Emphasis on Minimally Invasive Procedures: There is a significant shift towards minimally invasive surgical techniques, which require advanced bone cement formulations that cure rapidly and provide robust fixation with minimal tissue disruption. This trend is expected to drive innovations in bone cement products.
  • Increase in Research and Development Investments: Companies are investing heavily in research and development to innovate and improve bone cement formulations. This focus on R&D is expected to yield new products with enhanced properties such as greater mechanical strength and biocompatibility.
  • Expansion in Emerging Markets: The bone cement market is expanding rapidly in emerging markets within the Asia Pacific region. Improved healthcare infrastructure, rising disposable incomes, and increased awareness about orthopaedic treatments are contributing to this growth.
  • Partnerships and Collaborations: There is a growing trend of partnerships and collaborations between medical device companies and healthcare providers. These alliances aim to enhance product distribution, improve access to advanced bone cement products, and foster innovation through shared expertise.
The Asia Pacific bone cement market is evolving with a focus on innovation, customisation, and improved patient outcomes. These trends are set to shape the future of the market, making orthopaedic surgeries more effective and accessible across the region.

Asia Pacific Bone Cement Market Segmentation

Market Breakup by Product

  • Calcium Phosphate Cement (CPC)
  • Glass Polyalkenoate Cement
  • Polymethyl Methacrylate (PMMA) Cement
The Asia Pacific bone cement market is segmented by product into Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement, and Polymethyl Methacrylate (PMMA) Cement. PMMA cement dominates due to its widespread use in orthopaedic surgeries, driven by its rapid curing and high mechanical strength. Calcium Phosphate Cement is gaining traction for its biocompatibility and ability to promote bone growth, while Glass Polyalkenoate Cement is valued for its adhesion properties and reduced toxicity. Future growth is expected as advancements in these products continue, with PMMA leading the market and CPC showing significant potential for driving market growth during the forecast period.

Market Breakup by Application

  • Kyphoplasty
  • Arthroplasty
  • Vertebroplasty
The Asia Pacific bone cement market is segmented by application into Kyphoplasty, Arthroplasty, and Vertebroplasty. Arthroplasty, including hip and knee replacements, is the largest segment, driven by the ageing population and increasing prevalence of osteoarthritis. Vertebroplasty and Kyphoplasty are gaining momentum due to rising cases of vertebral compression fractures and osteoporosis. The future growth of these applications is bolstered by advancements in minimally invasive techniques and improved bone cement formulations. Kyphoplasty and Vertebroplasty are poised to drive market growth, offering enhanced patient outcomes and shorter recovery times during the forecast period.

Market Breakup by End User

  • Hospital
  • Ambulatory Surgical Centres
  • Clinics
The Asia Pacific bone cement market is segmented by end user into Hospitals, Ambulatory Surgical Centres, and Clinics. Hospitals dominate the market due to their advanced infrastructure and higher patient inflow for orthopaedic surgeries. Ambulatory Surgical Centres are witnessing significant growth, driven by the increasing preference for outpatient procedures and cost-effectiveness. Clinics also contribute to market expansion, particularly in urban areas with rising healthcare accessibility. Future growth in this segment is expected as technological advancements and improved healthcare infrastructure enhance the capabilities of these facilities, with Ambulatory Surgical Centres poised to drive market growth during the forecast period.

Market Breakup by Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
The Asia Pacific bone cement market is segmented by country into China, Japan, India, South Korea, and Australia. China and Japan dominate the market due to their advanced healthcare systems and increasing geriatric populations. India is experiencing rapid growth driven by expanding healthcare infrastructure and rising awareness of orthopaedic treatments. South Korea and Australia contribute significantly with high healthcare standards and increasing adoption of advanced medical technologies. Future growth in this market is expected as these countries continue to invest in healthcare advancements and address the growing demand for orthopaedic procedures, with China and India poised to drive significant market expansion during the forecast period.

Asia Pacific Bone Cement Market Competitive Landscape

The Asia Pacific bone cement market is highly competitive, with key players including Johnson & Johnson MedTech (DePuy Synthes), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Medtronic plc, DJO, LLC, Globus Medical, Inc., Arthrex, Inc., Cardinal Health, Inc., and Heraeus Medical LLC. Common market activities among these companies include mergers and acquisitions to expand their market presence, extensive research initiatives to develop advanced bone cement formulations, frequent product introductions to meet evolving clinical needs, and strategic partnerships to enhance distribution networks and technological capabilities. These activities are aimed at maintaining competitive advantage and driving market growth in the region.

Key Questions Answered in the Report

  • What is the current and future performance of the Asia Pacific bone cement market?
  • What are the main challenges facing the Asia Pacific bone cement market?
  • What are the key drivers of the Asia Pacific bone cement market?
  • What emerging trends are shaping the future of the Asia Pacific bone cement market?
  • What are the benefits of using antibiotic-loaded bone cement in reducing post-surgical infections?
  • What factors are driving the rapid expansion of the bone cement market in the Asia Pacific region?
  • What advancements are expected to drive future growth in the bone cement market, particularly for PMMA and CPC?
  • What factors are contributing to the significant growth of ambulatory surgical centres?
  • Why do China and Japan dominate the bone cement market?
  • What are the common strategies used by key players in the Asia Pacific bone cement market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Asia Pacific bone cement market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Asia Pacific bone cement market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Asia Pacific bone cement industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Bone Cement Market Overview
3.1 Global Bone Cement Market
3.1.1 Global Bone Cement Market Historical Value (2017-2023)
3.1.2 Global Bone Cement Market Forecast Value (2024-2032)
3.2 Asia Pacific Bone Cement Market
3.2.1 Asia Pacific Bone Cement Market Historical Value (2017-2023)
3.2.2 Asia Pacific Bone Cement Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Asia Pacific Bone Cement Market Landscape*
5.1 Asia Pacific Bone Cement: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Country
5.2 Asia Pacific Bone Cement: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 Asia Pacific Bone Cement Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Asia Pacific Bone Cement Market Segmentation (2017-2032)
7.1 Asia Pacific Bone Cement Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Calcium Phosphate Cement (CPC)
7.1.3 Glass Polyalkenoate Cement
7.1.4 Polymethyl Methacrylate (PMMA) Cement
7.2 Asia Pacific Bone Cement Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kyphoplasty
7.2.3 Arthroplasty
7.2.4 Vertebroplasty
7.3 Asia Pacific Bone Cement Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospital
7.3.3 Ambulatory Surgical Centres
7.3.4 Clinics
7.4 Asia Pacific Bone Cement Market (2017-2032) by Country
7.4.1 Market Overview
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 South Korea
7.4.6 Australia
8 China Bone Cement Market Segmentation (2017-2032)
8.1 China Bone Cement Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Calcium Phosphate Cement (CPC)
8.1.3 Glass Polyalkenoate Cement
8.1.4 Polymethyl Methacrylate (PMMA) Cement
8.2 China Bone Cement Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kyphoplasty
8.2.3 Arthroplasty
8.2.4 Vertebroplasty
8.3 China Bone Cement Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospital
8.3.3 Ambulatory Surgical Centres
8.3.4 Clinics
9 Japan Bone Cement Market Segmentation (2017-2032)
9.1 Japan Bone Cement Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Calcium Phosphate Cement (CPC)
9.1.3 Glass Polyalkenoate Cement
9.1.4 Polymethyl Methacrylate (PMMA) Cement
9.2 Japan Bone Cement Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kyphoplasty
9.2.3 Arthroplasty
9.2.4 Vertebroplasty
9.3 Japan Bone Cement Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospital
9.3.3 Ambulatory Surgical Centres
9.3.4 Clinics
10 India Bone Cement Market Segmentation (2017-2032)
10.1 India Bone Cement Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Calcium Phosphate Cement (CPC)
10.1.3 Glass Polyalkenoate Cement
10.1.4 Polymethyl Methacrylate (PMMA) Cement
10.2 India Bone Cement Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Kyphoplasty
10.2.3 Arthroplasty
10.2.4 Vertebroplasty
10.3 India Bone Cement Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospital
10.3.3 Ambulatory Surgical Centres
10.3.4 Clinics
11 South Korea Bone Cement Market Segmentation (2017-2032)
11.1 South Korea Bone Cement Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Calcium Phosphate Cement (CPC)
11.1.3 Glass Polyalkenoate Cement
11.1.4 Polymethyl Methacrylate (PMMA) Cement
11.2 South Korea Bone Cement Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Kyphoplasty
11.2.3 Arthroplasty
11.2.4 Vertebroplasty
11.3 South Korea Bone Cement Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospital
11.3.3 Ambulatory Surgical Centres
11.3.4 Clinics
12 Australia Bone Cement Market Segmentation (2017-2032)
12.1 Australia Bone Cement Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Calcium Phosphate Cement (CPC)
12.1.3 Glass Polyalkenoate Cement
12.1.4 Polymethyl Methacrylate (PMMA) Cement
12.2 Australia Bone Cement Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Kyphoplasty
12.2.3 Arthroplasty
12.2.4 Vertebroplasty
12.3 Australia Bone Cement Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospital
12.3.3 Ambulatory Surgical Centres
12.3.4 Clinics
13 Regulatory Framework
13.1 Regulatory Overview
13.2 Asia-Canada-Singapore-Switzerland (ACSS) Consortium
13.3 Central Drugs Standard Control Organisation (CDSCO)
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Asia Pacific
17.2 Johnson & Johnson Services, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Stryker Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Zimmer Biomet Holdings, Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Smith & Nephew plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 DJO, LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Globus Medical, Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Arthrex, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Cardinal Health, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Heraeus Medical LLC
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Asia Pacific Bone Cement Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Johnson & Johnson Services, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc
  • Smith & Nephew plc
  • Medtronic plc
  • DJO, LLC
  • Globus Medical, Inc
  • Arthrex, Inc.
  • Cardinal Health, Inc.
  • Heraeus Medical LLC

Methodology

Loading
LOADING...

Table Information